In-depth Insights by Lawyers in CA, OR, ME

Three Important “Drafting Tips” When Negotiating Cross Border Cannabis Transactions

As the world continues to shrink, cross border transactions continue to become more common, even in the cannabis field where more countries are legalizing both medicinal and recreational use of cannabis. Today, there are at least thirty countries that allow the cultivation, manufacturing and use of medicinal cannabis (Argentina, Australia, Chile, Czech Republic, Denmark, Germany, Israel, Thailand, etc.). A handful

Rogoway Law Group October 30, 2018

Assembly Bill 1793 – What it Means For Those With Prior California Cannabis Convictions

Governor Jerry Brown recently signed a number of cannabis bills that were passed within the last year into law. Assembly Bill 1793 should be of particular interest to those with California State cannabis convictions in their past. AB 1793 allows those with prior California cannabis convictions to have those convictions automatically dismissed or redesignated, depending on the type of prior

Rogoway Law Group October 24, 2018

Tilray's implications for “medicinal” cannabis companies

What the Heck Happened Last Week at Tilray? And its implications for “medicinal” cannabis companies.

What Tilray’s IPO means for “medicinal” cannabis companies? Tilray, Inc. describes itself as “a global pioneer in the research, cultivation, production, and distribution of medical cannabis and cannabinoids.” However, last week’s events make a pretty good case that Tilray (Nasdaq: TLRY) is not a pharmaceutical company after all despite being branded as one by companies like Yahoo Finance. This is very good

Rogoway Law Group September 25, 2018

Jana Adams administers a tincture high in CBD to her daughter, Brooke, who has Dravet Syndrome.

How a California Kindergartner Was Allowed to Take Her Cannabis Medicine to School

The Case Brooke Adams is a five-year-old girl diagnosed with Dravet Syndrome, a rare and severe form of epilepsy. Brooke currently uses medicinal cannabis-derived CBD oil to significantly reduce the frequency of seizures and medicinal cannabis-derived THC oil as an emergency medication to quickly stop seizures once they start. Brooke obtains both oils pursuant to a valid recommendation from a

Rogoway Law Group September 24, 2018

Los Angeles Cannabis Licenses: Phase II Eligibility Information

The City of Los Angeles anticipates opening up Phase II of its cannabis licensing process on August 1, 2018. To prepare potential applicants for the application process, the City released a set of guidelines that applicants can use to help establish eligibility for licensure. The document issued by the City is called Guidelines to Establish Eligibility Pursuant to LAMC Section

Rogoway Law Group July 20, 2018

New Compliance Challenges: California Consumer Privacy Act and the Cannabis Privacy Bill

Co-Author: Ken Stratton On June 28, 2018, California adopted a comprehensive consumer privacy act, the California Consumer Privacy Act of 2018 (the “CCPA”). Legislators rushed the CCPA through the legislative process with unpreceded speed to stave off a proposed, and more stringent, ballot initiative sponsored by a San Francisco developer. The law, which is similar in scope to the European

Rogoway Law Group July 19, 2018

On-Site Security Guard Requirements for Cannabis Retailers

New Local Cannabis Laws Proposed for San Francisco Raise Some Concerns

Co-Authored By: Charlie Lucero By now it’s well known that the City of San Francisco is considering two new cannabis laws: the first would be a local cannabis industry tax and the second would establish a new 9-member Cannabis Commission to oversee the industry within city limits. Last week, our attorneys attended a meeting sponsored by the San Francisco California

Rogoway Law Group July 5, 2018

FDA Approves Epidiolex: First Therapeutic Drug Made From Plant-Derived CBD

Co-Author: Josh Zetlin This week the U.S. Food and Drug Administration (FDA) approved Epidiolex as a treatment for seizures associated with two rare and severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. Epidiolex, developed by GW Pharmaceuticals plc (Nasdaq: GWPH), a UK-based pharmaceutical company with U.S. operations, is the first FDA-approved drug made from a purified substance derived from

Rogoway Law Group June 28, 2018

Insurance coverage for cannabis businesses in California

Selecting the Right Insurance for Your Cannabis Business

California cannabis licensees face a lot of risks, from business competition to regulatory uncertainty, to unforeseen disasters and lawsuits of all types. Cannabis companies can act to protect themselves from certain risk by obtaining specific types of insurance. State-Mandated Insurance Requirements for Cannabis Businesses While the state’s governing statute for commercial cannabis activity, MAUCRSA, does not require cannabis companies to

Rogoway Law Group June 15, 2018

Legal Insights